Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases


Posted in: Medical Condition News | Pharmaceutical News

Tags: Allergy, Antibody, Anti-Inflammatory, Arthritis, Blood, Breast Milk, Breastfeeding, Cancer, Cardiovascular Disease, Children, Clinical Trial, Cold, Cough, Diarrhea, Drugs, Fever, Flu, Gastroenteritis, Genetic, Headache, Health Care, Healthcare, Hepatitis B, Hepatitis C, HIV, Hives, Hospital, Immunology, Immunosuppression, Inflammatory Disease, Influenza, Joint Pain, Macrophage, Mediterranean Fever, Monoclonal Antibody, Muscle, Nausea, Necrosis, Neurological Disease, Pain, Placebo, Pneumonia, Rare Disease, Respiratory, Respiratory Disease, Rheumatology, Skin, Sore Throat, Stomach Pain, Tuberculosis, Tumor, Urinary Tract Infection, Vertigo, Vomiting, Weight Loss